|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||81.99 - 83.92|
|52 Week Range||67.65 - 95.82|
|Beta (5Y Monthly)||0.37|
|PE Ratio (TTM)||9.46|
|Earnings Date||Oct 29, 2020|
|Forward Dividend & Yield||3.15 (3.80%)|
|Ex-Dividend Date||May 04, 2020|
|1y Target Est||82.62|
As we (hopefully) approach the finish line in the COVID-19 vaccine race, it's a wonderful time to buy shares of Novavax and Sanofi.
Sanofi and the Parkinson's Foundation today announced a new research collaboration to advance the availability of genetic testing and counseling for people living with Parkinson's disease in the U.S. Over the next two years, Sanofi will provide $1 million in research funding to support the PD GENEration: Mapping the Future of Parkinson's Disease initiative.
Dr. Ebony Jade Hilton, Associate Professor of Anesthesiology and Critical Care Medicine at the University of Virginia; Co-Founder and Medical Director of GOODSTOCK Consulting LLC, joins Yahoo Finance's Akiko Fujita to discuss COVID-19 latest.